SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
SEC Accession No. 0001193125-18-009269
Filing Date
2018-01-12
Accepted
2018-01-11 20:19:02
Documents
1
Group Members
ALLERGAN HOLDINGS B1, INC.ALLERGAN W.C. HOLDING INC.ALLERGAN WC HOLDINGS IRELAND LTD (FORMERLY KNOWN AS WARNER CHILCOTT PLC)WARNER CHILCOTT LTD

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13D AMENDMENT NO. 3 d524170dsc13da.htm SC 13D/A 109568
  Complete submission text file 0001193125-18-009269.txt   111590
Mailing Address TEVA PHARMACEUTICAL INDUSTRIES LIMITED 5 BAZEL ST PO B 3190 PETACH TIKVA L3 49131
Business Address 5 BAZEL ST P O B 3190 PETACH TIKVA L3 49131 9729267267
TEVA PHARMACEUTICAL INDUSTRIES LTD (Subject) CIK: 0000818686 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L3 | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-55457 | Film No.: 18524547
SIC: 2834 Pharmaceutical Preparations

Mailing Address CLONSHAUGH BUSINESS AND TECHNOLOGY PARK COOLOCK, DUBLIN L2 D17 E400
Business Address CLONSHAUGH BUSINESS AND TECHNOLOGY PARK COOLOCK, DUBLIN L2 D17 E400 (216) 523-5000
Allergan plc (Filed by) CIK: 0001578845 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L2 | Fiscal Year End: 1231
Type: SC 13D/A
SIC: 2834 Pharmaceutical Preparations